Cardiac Stent

The stent with Exceptional Flexibility & Ultra-Thin Strut Thickness (60 to 65 µm)

Unique stent design together with proven efficacy of Sirolimus and Everolimus Drug & Biodegradable polymers resulted into stenoplus with excellent safety & efficacy profile.

Interventional Cardiology - Diversification

World Class Cardiology Solutions

A leading cardiology solutions manufacturer with a rapidly expanding portfolio benchmarked to the best, we design, develop, manufacture and market products which lean towards minimally invasive treatment. Our state-of-the art products address the correction of cardiac ailments at affordable prices with the best quality, safety and reliability.

Interventional Cardiology

FAQs

Our cardiac stents are CDSCO- Central Drug Standards Control Organization {Indian equivalent of the US FDA}, the DCGI - Drug Controller General of India, and are also certified by on CE 1434 standard besides adhering to the ISO EN 13485 metrics. On the European CE 1434 certification are Stenoflex, Everoshine, Trackmaster, Trackflex. Stenoplus and Trackplus are not yet CE certified.
On the Sirolimus eluting coronary stent system we offer Stenoflex, Trackflex, Stenoplus. On the Everolimus eluting coronary stent system we have Everoshine, Trackmaster, Trackplus.
Everoshine is an Everolimus eluting coronary stent system. It consisits of a stent made from cobalt chromium alloy and is coated with Everolimus, a drug used to prevent restenosis. This stent also includes a PTCA exchange balloon and bio-degradable polymers that control the elution of the drug after implantation.
Stenoflex is Sirolimus eluting coronary stent system used in interventional cardiology to support coronary arteries and maintain optimal blood flow.
Trackmaster is a part of Everoshine family of stents. It is designed for the treatment of coronary artery disease by helping keep arteries open after procedures such as Angioplasty.
Trackflex is a specification of the Stenoflex platform. This stent system combines an innovative stent design with a blend of bio-resorbable polymers.
Sirolimus and Everolimus are drugs used to prevent restenosis of arteries. Sirolimus is known for gradual drug release. Everolimus is an analog with similar properties but a shorter half life. Bio-degradable polymers used in these stents ensure that the drug is released over time and then degrades into harmless by-products subsequently flushed out by the body.
Benchmarked to best-in-class international standards, our stents have several distinguishing attributes: an ultra-low profile, excellent cross-ability and a flexible tip of the balloon catheter which help the entire stent system achieve perfect clinical outcomes. Low strut thickness compared to competitors is another advantage, as is unidirectional stent expansion.
Please contact us for your requirements.
You can purchase our cardiac stents directly from us.
We manufacture in accordance with MDR 2017 and complies with the requirements stipulated in the ISO and other applicable standards.
Yes, our cardiac stents are patended.
We have a robust after-sales support system which extends for upto 6 months or a year.
Among the world’s best, our stents last a liftime.
A semi complaint dilatation catheter, PTCA is advised for balloon dilatation of the stenotic portion of a coronary artery or for by-pass graft stenosis.
PTCA Dilation Catheter used for improving myocordial perfusion
We design, develop, produce ad test in-house.
Feedback from cardiac surgeons/cardiologists is very positive. We proactively seek clinical feedback and suggestions to constantly refine our products.